| Indications to perform this test: The APTT is
performed in
cases of suspected bleeding disorders. This test specifically evaluates the
common and intrinsic clotting pathway. The
extrinsic pathway is evaluated through the OSPT.
|
|
Coagulopathies and Hepatic Disease: The clotting factors are acute phase reactant proteins that are manufactured in the liver. In cases of hepatic disease, it is not uncommon to see coagulopathies as a result. Therefore, it is advisable to include clotting tests in your diagnostic workup of any case of suspected hepatic disease, especially if you are considering any invasive procedures like biopsies or fine needle aspirates.
The Test: The patient's plasma is mixed with partial
thromboplastin which is usually a rabbit brain extract which mimics the effect of platelet
phospholipid. The particulate activator may be diatomaceous earth, kaolin,
celite,
ellagic acid, or micronized silica. Because different commercial kits contain
different reagents, the clotting times will vary depending on the components. The
APTT will be prolonged with any deficiency of the intrinsic or common clotting factors, or
in the presence of inhibitors.
Plasma and Partial Thromboplastin + particulate activator + CaCl2
whole
blood clot
|
Interpretation of APTT results:
|
![]() |
For more information . . .